Champions Oncology
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- 210
- Market Cap
- -
- Introduction
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Turbine Unveils First-Ever Virtual Lab Platform for Cell Simulations in Drug Development
• Turbine has launched the world's first virtual lab using cell simulations, aligning with FDA's recent move to phase out animal testing requirements in drug development.
• The platform enables scientists to simulate experimental outcomes at unprecedented speed, with initial beta modules focusing on antibody-drug conjugate (ADC) payload selection and clinical positioning.
• Through a partnership with Champions Oncology, Turbine is building a virtual patient library with multi-omics data to predict therapeutic responses across diverse molecular subtypes, potentially transforming oncology R&D.
© Copyright 2025. All Rights Reserved by MedPath